| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 万鹏辉 | 国海证券 | 医药生物 | 35.99% | 33.34% | 19.08% | 100.00% | 5 | 0.00% | 2025-08-08 |
| 2 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 35.73% | 36.89% | 40.27% | 3.45% | 2 | -27.10% | 2025-04-03 |
| 3 | 张林晚 | 上海证券 | 医药生物 | 35.65% | 40.37% | 26.34% | -100.00% | 1 | -18.93% | 2025-07-22 |
| 4 | 刘浩 | 华创证券 | 医药生物 | 35.60% | 34.86% | 35.79% | 20.00% | 2 | -47.33% | 2025-05-16 |
| 5 | 韩世通 | 中信证券 | 医药生物 | 35.58% | 39.98% | 30.00% | -8.70% | 6 | -63.25% | 2025-07-16 |
| 6 | 韩世通 | 中信证券 | 医药生物 | 35.55% | 38.09% | 27.68% | -8.70% | 6 | -63.25% | 2025-07-14 |
| 7 | 仰佳佳 | 申万宏源 | 医药生物 | 35.55% | 35.44% | 20.78% | 16.67% | 1 | -37.64% | 2025-06-20 |
| 8 | 阳景 | 浦银国际证券 | 医药生物 | 35.52% | 39.79% | 19.20% | 100.00% | 4 | 0.00% | 2025-07-10 |
| 9 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 35.49% | 43.96% | 39.37% | 3.45% | 2 | -27.10% | 2025-04-15 |
| 10 | 顾资然 | 中信证券 | 医药生物 | 35.49% | 33.25% | 22.97% | 100.00% | 6 | 0.00% | 2025-08-07 |
| 11 | 仰佳佳 | 申万宏源 | 医药生物 | 35.48% | 35.25% | 36.06% | 16.67% | 4 | -37.64% | 2025-04-21 |
| 12 | 韩世通 | 中信证券 | 医药生物 | 35.42% | 43.26% | 29.00% | -8.70% | 6 | -63.25% | 2025-07-11 |
| 13 | 张林晚 | 上海证券 | 医药生物 | 35.37% | 42.27% | 33.25% | -100.00% | 1 | -18.93% | 2025-07-11 |
| 14 | 仰佳佳 | 申万宏源 | 医药生物 | 35.36% | 34.01% | 35.34% | 16.67% | 4 | -37.64% | 2025-04-22 |
| 15 | 阳景 | 浦银国际证券 | 医药生物 | 35.31% | 31.82% | 17.41% | 100.00% | 4 | 0.00% | 2025-06-13 |
| 16 | 马云涛 | 国元证券 | 医药生物 | 35.31% | 37.77% | 17.58% | -12.00% | 1 | -47.07% | 2025-08-08 |
| 17 | 仰佳佳 | 申万宏源 | 医药生物 | 35.30% | 37.47% | 34.16% | 16.67% | 1 | -37.64% | 2025-05-20 |
| 18 | 李蔚 | 中航证券 | 医药生物 | 35.28% | 39.58% | 34.14% | 0.00% | 7 | -49.52% | 2025-07-31 |
| 19 | 杨松 | 天风证券 | 医药生物 | 35.21% | 39.28% | 29.50% | -45.36% | 19 | -72.65% | 2025-07-17 |
| 20 | 袁聪敏 | 中信证券 | 医药生物 | 35.20% | 28.67% | 25.90% | 33.33% | 5 | -2.06% | 2025-04-22 |